From: Human biodistribution and dosimetry of [11C]-UCB-J, a PET radiotracer for imaging synaptic density
Target organ | Absorbed dose coefficients (mSv/MBq) | |||||
---|---|---|---|---|---|---|
Adult female | Adult female | Adult male | Average | Average [10] | % Difference | |
Adrenals | 3.26E−03 | 3.28E−03 | 2.57E−03 | 2.92E−03 ± 0.50 | 3.34E−03 | −12% |
Brain | 2.09E−02 | 1.69E−02 | 1.17E−02 | 15.30E−03 ± 5.09 | 1.85E−02 | −17% |
Breasts | 1.56E−03 | 1.66E−03 | 1.32E−03 | 1.47E−03 ± 0.21 | 1.75E−03 | −16% |
Gallbladder wall | 1.20E−02 | 4.14E−03 | 6.95E−03 | 7.51E−03 ± 0.79 | 1.22E−02 | −38% |
LLI wall | 3.62E−03 | 3.13E−03 | 2.95E−03 | 3.16E−03 ± 0.30 | 2.20E−02 | −86% |
Small intestine | 2.08E−02 | 1.43E−02 | 1.97E−02 | 18.63E−03 ± 1.52 | 2.83E−03 | 558% |
Stomach wall | 8.82E−03 | 5.27E−03 | 6.16E−03 | 6.60E−03 ± 0.63 | 6.83E−03 | −3% |
ULI wall | 8.55E−03 | 6.35E−03 | 7.96E−03 | 7.71E−03 ± 0.36 | 2.83E−03 | 173% |
Heart wall | 5.53E−03 | 5.19E−03 | 5.62E−03 | 5.49E−03 ± 0.18 | 4.44E−03 | 24% |
Kidneys | 1.57E−02 | 1.67E−02 | 7.29E−03 | 11.75E−03 ± 6.30 | 1.01E−02 | 16% |
Liver | 1.56E−02 | 1.52E−02 | 1.27E−02 | 14.05E−02 ± 1.91 | 1.98E−02 | −29% |
Lungs | 4.50E−03 | 4.25E−03 | 4.09E−03 | 4.23E−03 ± 0.20 | 5.24E−03 | −19% |
Muscle | 2.09E−03 | 2.09E−03 | 1.70E−03 | 1.90E−03 ± 0.28 | 2.11E−03 | −10% |
Ovaries | 4.05E−03 | 3.46E−03 | 3.31E−03 | 3.53E−03 ± 0.32 | 3.50E−03 | 1% |
Pancreas | 3.43E−03 | 3.23E−03 | 2.72E−03 | 3.03E−03 ± 0.43 | 3.37E−03 | −10% |
Red marrow | 4.21E−03 | 3.96E−03 | 3.77E−03 | 3.93E−03 ± 0.22 | 2.22E−03 | 77% |
Osteogenic cells | 4.69E−03 | 4.63E−03 | 3.42E−03 | 4.04E−03 ± 0.88 | 3.11E−03 | 30% |
Skin | 1.53E−03 | 1.59E−03 | 1.25E−03 | 1.41E−03 ± 0.22 | 1.64E−03 | −14% |
Spleen | 4.35E−03 | 4.57E−03 | 2.40E−03 | 3.43E−03 ± 1.46 | 4.60E−03 | −25% |
Testes | 1.43E−03 | 1.43E−03 | 2.16E−03 | −34% | ||
Thymus | 1.82E−03 | 1.95E−03 | 1.55E−03 | 1.72E−03 ± 0.24 | 2.06E−03 | −16% |
Thyroid | 1.59E−03 | 1.71E−03 | 1.49E−03 | 1.57E−03 ± 0.11 | 1.87E−03 | −16% |
Urinary bladder wall | 3.50E−02 | 2.62E−02 | 1.59E−02 | 23.25E−02 ± 4.84 | 2.21E−02 | 5% |
Uterus | 4.43E−03 | 3.76E−03 | 3.41E−03 | 3.75E−03 ± 0.48 | 3.21E−03 | 17% |
Total body | 3.33E−03 | 3.15E−03 | 2.56E−03 | 2.90E−03 ± 0.48 | 3.12E−03 | −7% |
Effective dose coefficient (mSv/MBq) (ICRP 60) | 6.53E−03 | 5.35E−03 | 4.91E−03 | 5.43E−03 ± 0.73 | 7.59E−03 | −28% |